Johnson Johnson AbbVie: Paths to Pharma Dominance
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Explore when to make changes to your spending plan and how to rebalance categories so you stay aligned with goals and cash flow.
23,566 articlesJohnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Oracle stock sinks to a fresh 52-week low as a rating downgrade raises capital-structure questions while AI ambitions...
PayPal shares surged following unconfirmed reports of a joint takeover bid by Stripe and Advent International, valued...
Lucid Group sparked a sharp rally after the CEO denied bankruptcy rumors and take-private chatter. This article break...
What happens when mega-stars perform for a cause rather than a paycheck? This article unpacks the no-fee halftime sho...
Rivian's shares fell despite peers seeing price-target bumps as investors weigh the upcoming R2 launch. This guide br...
After more than a month of walkouts, the york nurses union wins a tentative contract with NewYork-Presbyterian that i...
Virginia-based City Lending Inc. is winding down operations as regulators tighten oversight and the mortgage market c...
UWM posted about $163.4 billion in 2025 originations, a 17% rise from 2024, fueled by a refinancing surge. The lender...
A vivid look at the origins of Amazon’s empire and the investors who struck it rich long ago. Learn the core moves th...
A major shift in ServiceNow's strategy, led by aggressive AI integration and larger enterprise contracts, could set t...
A fresh $3.4 million investment in Northeast Bank by PMC FIG Opportunities highlights growing interest in regional le...